www.fdanews.com/articles/166386-fda-warns-compounding-pharmacy-trio-with-cgmp-violations
FDA Warns Compounding Pharmacy Trio With cGMP Violations
August 8, 2014
The FDA cited a trio of compounders for a wide swath of quality violations, igniting renewed criticism that the agency is “unjustified” in using a new law to enforce old violations.
Drug Industry Daily